Position in TMO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,118,246
+$170,805 QoQ
Shares Held
4,225
+6.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#1,142
of 2,606 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DOVER ADVISORS, LLC holds $2,118,246 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
4,225 | $2,118,246 |
All Filings in TMO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,118,246 | 4,225 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,947,441 | 3,962 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $2,448,176 | 4,225 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,974,031 | 4,070 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,647,789 | 4,064 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $2,157,096 | 4,335 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,939,417 | 3,728 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $2,269,533 | 3,669 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,911,721 | 3,457 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,009,242 | 3,457 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,242,048 | 2,340 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,615,694 | 3,192 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,652,904 | 3,168 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,814,412 | 3,148 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,524,860 | 2,769 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||